ArticleFrontiers in pharmacology2022

Clinical study of lenvatinib in the treatment of hepatitis virus-related hepatocellular carcinoma and antiviral therapy.

Xiaomi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.